Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3H2101
Mon, 15.05.2023
aap Implantate AG
Sales: EUR 3.0 million (+3 % yoy; CER[1] : +2 % yoy); LATAM (+55 % yoy) and USA (+15 % yoy) with significant double-digit growth; EMEA with -9 % yoy remains below expectations
EBITDA unchanged year-on-year at EUR -0.5 million in cost- and interest-rate-inflationary environment; operating cash flow +74 % year-on-year
Silver: Clinical trial resu [ … ]
Mon, 15.05.2023
aap Implantate AG
Sales: EUR 3.0 million (+3 % yoy; CER[1] : +2 % yoy); LATAM (+55 % yoy) and USA (+15 % yoy) with significant double-digit growth; EMEA with -9 % yoy remains below expectations
EBITDA unchanged year-on-year at EUR -0.5 million in cost- and interest-rate-inflationary environment; operating cash flow +74 % year-on-year
Silver: Clinical trial resu [ … ]
Fri, 28.04.2023
aap Implantate AG
Sales: EUR 11.5 million (-6 % yoy; CER[1] : -9 % yoy); markets generally in difficult environment with mixed results; USA in H2/2022 with solid growth and excluding one-off effects +16 % yoy
EBITDA: EUR -1.7 million (FY/2021: EUR -0.8 million); operating cash flow +23 % yoy
Silver: Release revised study protocol in Q4/2022 with restart study i [ … ]
Fri, 28.04.2023
aap Implantate AG
Sales: EUR 11.5 million (-6 % yoy; CER[1] : -9 % yoy); markets generally in difficult environment with mixed results; USA in H2/2022 with solid growth and excluding one-off effects +16 % yoy
EBITDA: EUR -1.7 million (FY/2021: EUR -0.8 million); operating cash flow +23 % yoy
Silver: Release revised study protocol in Q4/2022 with restart study i [ … ]
Mon, 03.04.2023
aap Implantate AG
aap Implantate AG (“aap”) announces that its US subsidiary aap Implants Inc has been awarded a group purchasing agreement for the “Small Joint Implants – Upper Extremities” “Small Joint Implants - Lower Extremities, Podiatry Products and Accessories” portfolio with Premier, Inc., effective as of March 1, 2023. The agreement allows Premier members, [ … ]
Mon, 03.04.2023
aap Implantate AG
aap Implantate AG (“aap”) announces that its US subsidiary aap Implants Inc has been awarded a group purchasing agreement for the “Small Joint Implants – Upper Extremities” “Small Joint Implants - Lower Extremities, Podiatry Products and Accessories” portfolio with Premier, Inc., effective as of March 1, 2023. The agreement allows Premier members, [ … ]
Tue, 21.03.2023
aap Implantate AG
aap Implantate AG (“aap”) announces that its new system LOQTEQ® VA Elbow 2.7/3.5 has been cleared by the US-American Food and Drug Administration (FDA). The Company plans to launch the system LOQTEQ® VA Elbow 2.7/3.5 in the fourth quarter of 2023 in the United States and in other markets that accept FDA clearances. The system enables flexible treat [ … ]
Tue, 21.03.2023
aap Implantate AG
aap Implantate AG (“aap”) announces that its new system LOQTEQ® VA Elbow 2.7/3.5 has been cleared by the US-American Food and Drug Administration (FDA). The Company plans to launch the system LOQTEQ® VA Elbow 2.7/3.5 in the fourth quarter of 2023 in the United States and in other markets that accept FDA clearances. The system enables flexible treat [ … ]
Wed, 15.03.2023
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") announces that, following completion of the private placement as part of the capital increase with subscription rights, the capital measure has been fully subscribed. The Management Board of the Company participated in the capital measure to the extent of EUR 0.4 million.
On 15 Marc [ … ]
Wed, 15.03.2023
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") announces that, following completion of the private placement as part of the capital increase with subscription rights, the capital measure has been fully subscribed. The Management Board of the Company participated in the capital measure to the extent of EUR 0.4 million.
On 15 Marc [ … ]